Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients

Steven E. Lipshultz, Stacy D. Fisher, Wyman W. Lai, Tracie L. Miller

Research output: Contribution to journalReview article

30 Scopus citations

Abstract

Cardiovascular complications are important contributors to morbidity and mortality in HIV-infected patients. These complications can usually be detected at subclinical levels with monitoring, which can help guide targeted interventions. This article reviews available data on types and frequency of cardiovascular manifestations in HIV-infected patients and proposes monitoring strategies aimed at early subclinical detection. In particular, we recommend routine echocardiography for HIV-infected patients, even those with no evidence of cardiovascular disease. We also review preventive and therapeutic cardiovascular interventions. For procedures that have not been studied in HIV-infected patients, we extrapolate from evidence-based guidelines for the general population.

Original languageEnglish (US)
Pages (from-to)S96-S122
JournalAIDS
Volume17
Issue numberSUPPL. 1
DOIs
StatePublished - Apr 2003

Keywords

  • AIDS
  • Atherosclerosis
  • Cardiomyopathy
  • Cardiovascular preventive care
  • Congestive heart failure
  • Guidelines
  • HIV
  • Lipodystrophy
  • Pericarditis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases
  • Health(social science)

Fingerprint Dive into the research topics of 'Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients'. Together they form a unique fingerprint.

  • Cite this

    Lipshultz, S. E., Fisher, S. D., Lai, W. W., & Miller, T. L. (2003). Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. AIDS, 17(SUPPL. 1), S96-S122. https://doi.org/10.1097/00002030-200304001-00014